| 2025-04-24 | +6.25 % |
|
| 2025-04-23 | +5.12 % |
|
| 2025-04-22 | +1.75 % |
|
| 2025-04-17 | -2.12 % |
|
| 2025-04-16 | -4.82 % |
|
| 2025-04-15 | +0.85 % |
|
| 2025-04-11 | +1.58 % |
|
| 2025-04-08 | -3.14 % |
|
| 2025-04-07 | +5.26 % |
|
| 2025-04-04 | -9.4 % |
|
| 2025-04-03 | -11.6 % |
|
| 2025-03-21 | -2.21 % |
|
| 2025-03-19 | +0.74 % |
|
| 2025-03-13 | -1.74 % |
|
| 2025-03-10 | -6.58 % |
|
| 2025-03-04 | +0.87 % |
|
| 2025-02-28 | +0.75 % |
|
| 2025-02-25 | -3.66 % |
|
| 2025-02-19 | +1.25 % |
|
| 2025-02-18 | +4.63 % |
|
| 2025-02-07 | -0.6 % |
|
| 2025-02-06 | +1.09 % |
|
| 2025-02-05 | +2.54 % |
|
| 2025-02-03 | -1.06 % |
|
| 2025-01-31 | +0.4 % |
|
| 2025-01-29 | +0.86 % |
|
| 2025-01-27 | -5.08 % |
|
| 2025-01-24 | -1.91 % |
|
| 2025-01-23 | -2.43 % |
|
| 2025-01-21 | +1.49 % |
|
| 2025-01-17 | +1.36 % |
|
| 2025-01-16 | +4.03 % |
|
| 2025-01-14 | +0.82 % |
|
| 2025-01-10 | -3.1 % |
|
| 2025-01-08 | -0.62 % |
|
| 2025-01-07 | -0.59 % |
|
| 2025-01-06 | +3.82 % |
|
| 2025-01-03 | +3.69 % |
|
| 2024-12-20 | +0.81 % |
|
| 2024-12-13 | +0.9 % |
|
| 2024-12-12 | -3.39 % |
|
| 2024-12-09 | +1.12 % |
|
| 2024-12-06 | +1.83 % |
|
| 2024-12-04 | -0.1 % |
|
| 2024-11-29 | +3.23 % |
|
| 2024-11-27 | -1.54 % |
|
| 2024-11-22 | -0.67 % |
|
| 2024-11-21 | +4.4 % |
|
| 2024-11-20 | -0.17 % |
|
| 2024-11-08 | -1.28 % |
|
| 2024-11-05 | +3.01 % |
|
| 2024-10-31 | -2.75 % |
|
| 2024-10-30 | -2.38 % |
|
| 2024-10-29 | +3.79 % |
|
| 2024-10-28 | -2.87 % |
- The article discusses that Lam Research (LRCX) stock recently decreased by 2.87%, prompting questions about whether it is time to sell. The decline in Lam Research's stock is attributed to broader market trends and specific concerns about the semiconductor industry's demand outlook.
- Lam Research (LRCX) stock fell by 2.87% following a series of price target reductions from multiple investment analysts, despite the company reporting earnings that exceeded estimates and growth in revenue.
- Lam Research (LRCX) stock declined by 2.87% after First Financial Bankshares Inc significantly reduced its holdings in the company by 75.7% during the third quarter.
- Lam Research Co. (LRCX) stock fell by 2.87% following the company's recent earnings report, despite beating earnings expectations, due to concerns over institutional investors reducing their holdings and mixed analyst ratings suggesting a cautious outlook.
- Lam Research (LRCX) shares fell 2.87% after Wells Fargo cut its target price for the stock from $88.00 to $85.00 and maintained an equal weight rating, reflecting a cautious outlook amidst varying assessments from other research firms.
- Lam Research (LRCX) stock fell by 2.87%, primarily due to concerns regarding its exposure to China and analysts' belief that its shares may have been overvalued in anticipation of a full recovery, as evidenced by funds reallocating their investments towards other tech stocks like Broadcom (AVGO).
- Lam Research (LRCX) stock experienced a decline of 2.87% last night, possibly due to broader market trends affecting tech stocks, concerns about semiconductor demand, or negative investor sentiment.
|
| 2024-10-25 | +1.45 % |
- Lam Research (LRCX) stock rose by 1.45% last night, likely due to Cullinan Associates Inc. significantly increasing its holdings in the company by 900% during the third quarter, indicating strong institutional confidence in the stock.
- Lam Research (LRCX) stock rose by 1.45% due to positive market trends and investor confidence in the semiconductor industry, likely driven by strong demand for chips and advancements in technology.
- Lam Research (LRCX) stock increased by 1.45% likely due to broader bullish sentiment in the tech sector, particularly the emphasis on artificial intelligence investments by major tech companies, which is driving demand for semiconductor-related stocks.
- Lam Research (LRCX) stock rose by 1.45% due to increased institutional investment, including a significant 38.6% stake increase by Hennion & Walsh Asset Management, along with positive quarterly earnings that surpassed analyst expectations.
- Lam Research (LRCX) stock rose by 1.45% after the company reported better-than-expected quarterly earnings and revenue, with EPS of $0.86, beating analysts' estimates of $0.81 and revenue of $4.17 billion exceeding the projected $4.06 billion, despite several recent target price adjustments from analysts.
|
